Literature DB >> 27468915

First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome.

H Ziada-Bouchaar1,2, K Sifi3, T Filali3,4, T Hammada3,5, D Satta6,3, N Abadi3.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by the early onset of colorectal cancer (CRC) linked to germline defects in Mismatch Repair (MMR) genes. We present here, the first molecular study of the correlation between CRC and mutations occurring in these genes performed in twenty-one unrelated Algerian families. The presence of germline mutations in MMR genes, MLH1, MSH2 and MSH6 genes was tested by sequencing all exons plus adjacent intronic sequences and Multiplex ligand-dependent probe amplification (MLPA) for testing large genomic rearrangements. Pathogenic mutations were identified in 20 % of families with clinical suspicion on HNPCC. Two novel variants described for the first time in Algerian families were identified in MLH1, c.881_884delTCAGinsCATTCCT and a large deletion in MSH6 gene from a young onset of CRC. Moreover, the variants of MSH2 gene: c.942+3A>T, c.1030C>T, the most described ones, were also detected in Algerian families. Furthermore, the families HNPCC caused by MSH6 germline mutation may show an age of onset that is comparable to this of patients with MLH1 and MSH2 mutations. In this study, we confirmed that MSH2, MLH1, and MSH6 contribute to CRC susceptibility. This work represents the implementation of a diagnostic algorithm for the identification of Lynch syndrome patients in Algerian families.

Entities:  

Keywords:  Algerian families; Hereditary non-polyposis colorectal cancer; Lynch syndrome; MLH1; MMR genes

Mesh:

Substances:

Year:  2017        PMID: 27468915     DOI: 10.1007/s10689-016-9917-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  43 in total

1.  Identification of lynch syndrome: are we close to the best strategy?

Authors:  Francesc Balaguer; Antoni Castells
Journal:  Gastroenterology       Date:  2007-07       Impact factor: 22.682

2.  Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals.

Authors:  Mev Dominguez Valentin; Felipe Carneiro da Silva; Erika Maria Monteiro dos Santos; Bianca Garcia Lisboa; Ligia Petrolini de Oliveira; Fabio de Oliveira Ferreira; Israel Gomy; Wilson Toshihiko Nakagawa; Samuel Aguiar Junior; Mariana Redal; Carlos Vaccaro; Adriana Della Valle; Carlos Sarroca; Dirce Maria Carraro; Benedito Mauro Rossi
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

Review 3.  Epigenetic mechanisms in the pathogenesis of Lynch syndrome.

Authors:  P Peltomäki
Journal:  Clin Genet       Date:  2014-02-17       Impact factor: 4.438

4.  A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome.

Authors:  N J Froggatt; J A Joyce; R Davies; D Gareth; R Evans; B A Ponder; D E Barton; E R Maher
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

5.  Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.

Authors:  Trilokesh D Kidambi; Amie Blanco; Megan Myers; Peggy Conrad; Kate Loranger; Jonathan P Terdiman
Journal:  Dig Dis Sci       Date:  2014-06-06       Impact factor: 3.199

6.  Lynch syndrome in Tunisia: first description of clinical features and germline mutations.

Authors:  Sana Aissi-Ben Moussa; Amel Moussa; Nadia Kourda; Amel Mezlini; Nabil Abdelli; Farid Zerimech; Taoufik Najjar; Sarah Ben Jilani; Nicole Porchet; Farhat Ben Ayed; Mohamed Manai; Marie-Pierre Buisine
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 7.  Microsatellite instability: an update.

Authors:  Hiroyuki Yamamoto; Kohzoh Imai
Journal:  Arch Toxicol       Date:  2015-02-22       Impact factor: 5.153

8.  High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country.

Authors:  Cristina Martínez-Bouzas; Enrique Ojembarrena; Elena Beristain; Javier Errasti; Noelia Viguera; Maria-Isabel Tejada Minguéz
Journal:  Cancer Lett       Date:  2007-06-19       Impact factor: 8.679

9.  Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.

Authors:  Sarah Mange; Cecelia Bellcross; Deborah Cragun; Deb Duquette; Lisa Gorman; Heather Hampel; Kory Jasperson
Journal:  J Genet Couns       Date:  2014-09-16       Impact factor: 2.537

10.  UMD-MLH1/MSH2/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families.

Authors:  Philippe Grandval; Aurélie J Fabre; Pascaline Gaildrat; Stéphanie Baert-Desurmont; Marie-Pierre Buisine; Anthony Ferrari; Qing Wang; Christophe Béroud; Sylviane Olschwang
Journal:  Database (Oxford)       Date:  2013-05-31       Impact factor: 3.451

View more
  3 in total

1.  A new hereditary colorectal cancer network in the Middle East and eastern mediterranean countries to improve care for high-risk families.

Authors:  Zeinab Ghorbanoghli; Carol Jabari; Walid Sweidan; Wail Hammoudeh; George Cortas; Ala I Sharara; Amal Abedrabbo; Ijad Hourani; Bahareh Mahjoubi; Keivan Majidzadeh; Nurdan Tözün; Hadia Ziada-Bouchaar; Waseem Hamoudi; Osama Diab; Hamid Reza Khorram Khorshid; Henry Lynch; Hans Vasen
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

Review 2.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

3.  A Rare MSH2 Variant as a Candidate Marker for Lynch Syndrome II Screening in Tunisia: A Case of Diffuse Gastric Carcinoma.

Authors:  Maria Kabbage; Jihenne Ben Aissa-Haj; Houcemeddine Othman; Amira Jaballah-Gabteni; Sarra Laarayedh; Sahar Elouej; Mouna Medhioub; Haifa Tounsi Kettiti; Amal Khsiba; Moufida Mahmoudi; Houda BelFekih; Afifa Maaloul; Hassen Touinsi; Lamine Hamzaoui; Emna Chelbi; Sonia Abdelhak; Mohamed Samir Boubaker; Mohamed Mousaddak Azzouz
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.